Advertisement

Cyclic Nucleotides and Related Mechanisms in Immune Regulation : A Mini Review

  • John W. Hadden

Abstract

Much of the study of immune regulation over the last twenty years has focused on the dissection of cellular function and interactions “in vitro”. While clearly “in vivo” studies have supported the models of regulation which have derived, this type of extrapolative approach tells only part of the story of immune regulation. The “in vitro” studies generally employ artificial media containing a drab of serum often from different species; they do not pretend to offer a dynamic fluid environment akin to that which exists “in vivo”. It is becoming abundantly clear that the immune system operates “in vivo” within a homeostatic milieu replete with neurologic, neuroendocrine, endocrine and microenvi-ronmental regulatory influences clearly as complex as those regulating the internal network of intercommunication among the cells of the system.

Keywords

Migration Inhibitory Factor Cyclic Nucleotide Guanylate Cyclase Immune Regulation Arachidonic Acid Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ananthakrishman, R., Coffey, R.G., and Hadden, J.W., 1981, Cyclic GMP and Calcium in lymphocyte activation by phytohemagglutinin, Lymphocyte Differentiation, in press.Google Scholar
  2. Astaldi, A., Astaldi, G.C.B., Schellekens, P.T.A., and Eijsvoogel, V.P., 1976, Thymic factor in human sera demonstrable by a cyclic AMP assay, Nature, 260:713.PubMedCrossRefGoogle Scholar
  3. Attallah, A.M., and Houck, J.C., 1977, Tentative mechanisms of lymphocyte chalone action, Exp. Cell Res., 105:137.PubMedCrossRefGoogle Scholar
  4. Bach, M.A., 1977, Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor, J. Immunol., 119:641.PubMedGoogle Scholar
  5. Balow, J.E., and Rosenthal, A.S., 1973, Glucocorticoid suppression of macrophage migration inhibitory factor, J. Exp. Med., 137:1031.PubMedCrossRefGoogle Scholar
  6. Bar, R.S., and Kahn, R.C., 1977, Insulin inhibition of antibody-dependent cytotoxicity and insulin receptors in macrophages, Nature, 265:632.PubMedCrossRefGoogle Scholar
  7. Bass, D.A., O’Flaherty, J.T., Szejda, P., De Chatelet, L.R., McCall, C.E., 1980, Role of arachidonic acid in stimulation of hexose transport by human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci., USA, 77:5125.PubMedCrossRefGoogle Scholar
  8. Bendtzen, K., and Klysner, R., 1979, Increased polymorphonuclear leukocyte cGMP levels induced by the human lymphokine, leukocyte migration inhibitory factor (LIF), Immunopharmacol., 1:323.CrossRefGoogle Scholar
  9. Bendtzen, K., Mahoney, R., and Rocklin, R.E., 1981, Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulation with phytohemagglutinin. II. Effects of cyclic nucleotides, Clin. Immunol. Immunopathol., 18:221.PubMedCrossRefGoogle Scholar
  10. Block, L.H., Aloni, B., Biemesderfer, D., Kashgarian, M., and Bitensky, M.W., 1978, Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP, J. Immunol., 121:1416.PubMedGoogle Scholar
  11. Bromberg, Y., and Pick, E., 1980, Cyclic GMP metabolism in macrophages. I. Regulation of cyclic GMP levels by calcium and stimulation of cyclic GMP synthesis by NO-generation agents, Cell. Immunol., 52:73.PubMedCrossRefGoogle Scholar
  12. Brune, K., Glatt, M., and Kalin, H., 1978, Pharmacological control of prostaglandin and thromboxane release from macrophages, Nature, 274:261.PubMedCrossRefGoogle Scholar
  13. Carpentieri, U., Monahan, T.M., and Gustavson, L.P., 1980, Observations of the level of cyclic nucleotides in three populations of human lymphocytes in culture, J. Cyc. Nucl. Res., 4:253.Google Scholar
  14. Chedid, L., Carelli, C., and Audibert, F., 1979, Recent developments concerning muramyl dipeptide, a synthetic immunoregula-ting molecule, J. Reticuloendothel. Soc., 26 (Supp.):631.PubMedGoogle Scholar
  15. Coffey, R.G., and Hadden, J.W., 1981a, Arachidonate and metabolites in mitogen activation of lymphocyte guanylate cyclase, in: “Advances in Immunopharmacology,” J. Hadden, L. Chedid, P. Mullen and F. Spreafico, eds., Pergamon Press, Oxford, p. 365.Google Scholar
  16. Coffey, R.G., and Hadden, J.W., 1981b, Phytohemagglutinin stimulation of guanylate cyclase in human lymphocytes, J. Biol. Chem., 256:4418.PubMedGoogle Scholar
  17. Coffey, R.G., Hadden, J.W., and Middleton, E.J.R., 1974, Increased adenosine triphosphatase in leukocytes of asthamatic children, J. Clin. Invest., 54:138.PubMedCrossRefGoogle Scholar
  18. Coffey, R.G., Hadden, E.M., and Hadden, J.W., 1975, Norepinephrine stimulation of membrane ATPase in human lymphocytes, Endocrinol. Res. Comm., 12:179.Google Scholar
  19. Coffey, R.G., Hadden, E.M., and Hadden, J.W., 1977, Evidence of cyclic GMP and calcium mediation of lymphocyte activation by mitogens, J. Immunol.,, 119:1387.PubMedGoogle Scholar
  20. Coffey, R.G., Hadden, E.M., Lopez, C., and Hadden, J.W., 1978, Cyclic GMP and calcium in the initiation of cellular proliferation, Adv. Cyclic Nucl. Res., 9:66.Google Scholar
  21. Dessaint, J., Waksman, B.H., Metzger, H., and Capron, A., 1980, Cytophilic binding of IgE to the macrophage. III. Involvement of cyclic GMP and calcium in macrophage activation by dimeric or aggregated rat myeloma IgE, Cell. Immunol., 51:280.PubMedCrossRefGoogle Scholar
  22. Duncan, M.R., Sadlik, J.R., and Hadden, J.W., 1981, Glucocorticoid modulation of lymphokine-induced macrophage proliferation, J. Immunol., submitted.Google Scholar
  23. Eckels, D.D., and Gershwin, M.E., 1981, Pharmacologic and biochemical modulation of human T-lymphocyte colony formation:hormonal influences, ImmunoPharmacol., 2:259.CrossRefGoogle Scholar
  24. Foster, S., 1980, Cyclic nucleotides and cellular secretion. Cyclic nucleotides, possible intracellular mediators of macrophage activation and secretory processes, Agents and Actions, 10:556.PubMedCrossRefGoogle Scholar
  25. Freedman, M.H., 1979, Early biochemical events in lymphocyte activation. I. Investigations on the nature and significance of early calcium fluxes observed in mitogen induced T and B lymphocytes, Cell. Immunol., 44:290.Google Scholar
  26. Gallin, J., Sandler, J.A., Clyman, R.I., Manganiello, V.C. and Vaughan, M., 1978, Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion, J. Immunol., 120:492.PubMedGoogle Scholar
  27. Goetzl, E.J., and Pickett, W.C., 1980, The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs), J. Immunol., 125:1789.PubMedGoogle Scholar
  28. Goetzl, E.J., and Sun, F.F., 1979, Generation of unique mono-hydroxy-eicosate-traenoic acids from arachidonic acid by human neutrophils, J. Exp. Med., 150:406.PubMedCrossRefGoogle Scholar
  29. Goetzl, E.J., Hill, H.R., and Gorman, R.R., 1980, Unique aspects of the modulation of human neurophil function by 12-L-lydroperoxy-f, 8, 10, 14-eicosategraenoic acid, Prostaglandins, 19:71.PubMedCrossRefGoogle Scholar
  30. Goldberg, N.D., Hadden, M.K., Durham, E., Lopez, C., and Hadden, J.W., 1974, Evidence for opposing influences of cyclic GMP and cyclic AMP in the regulation of cell proliferation and other biological processes. Cold Spring Harbor Symposium “Control of proliferation in Animal Cells,” Cold Spring Harbor Press, New York, p. 609.Google Scholar
  31. Goldstein, I.M., Malmsten, C.L., Kindahl, H., Kaplan, H.B., Radmark, O., Samuelsson, B., and Weissman, G., 1978, Thromboxane generation by human peripheral blood polymorphonuclear leukocytes, J. Exp. Med., 148:787.PubMedCrossRefGoogle Scholar
  32. Goodwin, J.S., Bromberg, S., and Messner, R.P., 1981, Studies on the cyclic AMP response to prostaglandin in human lymphocytes, Cell. Immunol., 60:298.PubMedCrossRefGoogle Scholar
  33. Gordon, D., Bray, M.A., Morley, J., 1976, Control of lymphokine secretion by prostaglandins, Nature, 262:401.PubMedCrossRefGoogle Scholar
  34. Gupta, S., 1979, Subpopulations of human T lymphocytes. XII. In vitro effect of agents modifying intracellular levels of cyclic nucleotides on T cells with receptors for IgM (Tμ), IgG (Tγ), or IgA (Tα), J. Immunol, 123:2664.PubMedGoogle Scholar
  35. Hadden, J.W., 1977, Cyclic nucleotides in lymphocyte proliferation and differentiation, in: “Immunopharmacology,” Hadden, J.W., Coffey, R.G., and Spreafico, F., eds., vol 3, Plenum Publishing Corp., New York, p. 1.CrossRefGoogle Scholar
  36. Hadden, J.W., 1978, The action of immunopotentiators in vitro on lymphocyte and macrophage activation, in: “The Pharmacology of Immunoregulation,” Werner, G.H. and Floe’h, F., eds., Academic Press, New York, p. 369.Google Scholar
  37. Hadden, J.W., and Englard, A., 1977, Molecular aspects of macrophage activation and proliferation, in: “Immunopharmacology,” Hadden, J.W., Coffey, R.G. and Spreafico, F., eds., vol. 3, Plenum Publishing Corp., New York, p. 87.CrossRefGoogle Scholar
  38. Hadden, J.W., and Englard, A., 1979, Molecular aspects of macrophage activation and proliferation, in: “10th Int. Course on Transplantation and Clinical Immunology,” Excerpta Medica, Amsterdam, p. 279.Google Scholar
  39. Hadden, J.W., Hadden, E.M., and Middleton, E., jr. 1970, Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes, J. Cell. Immunol., 1:583.Google Scholar
  40. Hadden, J.W., Hadden, E.M., Wilson, E.E., Good, R.A., and Coffey, R.G., 1972, Direct action of insulin on plasma membrane ATPase activity in human lymphocytes, Nature, New Biol., 235:174.PubMedCrossRefGoogle Scholar
  41. Hadden, J.W., Hadden, E.M., Coffey, R.G., Johnson, E.M., and Johnson, L.D., 1975, Cyclic GMP and lymphocyte activation, in: “Immune Recognition,” A. Rosenthal., ed., Academic Press, New York, p. 359.Google Scholar
  42. Hadden, J.W., Coffey, R.G., and Spreafico, F., 1977, Immunopharmacology, vol. 3, Plenum Publishing Corp, New York.CrossRefGoogle Scholar
  43. Hadden, J.W., Sadlik, J.R., and Hadden, E.M., 1978, The induction of macrophage proliferation in vitro by a lymphocyte produced factor, J. Immunol., 121:231.PubMedGoogle Scholar
  44. Hadden, J.W., Sadlik, J.R., Englard, A., Warfel, A., and Hadden, E., 1979a, Lymphokine-induced macrophage proliferation, activation, and fusion, in: “Biochemical Characterization of the Lymphokines,” A. DeWeck, ed., Academic Press, New York, p. 235.Google Scholar
  45. Hadden, J.W., Ehglard, A., Sadlik, J.R., and Hadden, E., 1979b, The comparative effects of isoprinosine, levamisole, muramyl dipep-tide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro, Int. J. Immunopharmacol., 1:17.PubMedCrossRefGoogle Scholar
  46. Hadden, J.W., Coffey, R.G., Ananthakrishnan, R., and Hadden, E.M., 1979c, Cyclic nucleotides and calcium in lymphocyte regulation and activation, Proc. N.Y. Acad. Sci., 332:241.CrossRefGoogle Scholar
  47. Hagmann, J., and Fishman, P.H., 1980, Modulation of adenylate cyclase in intact macrophages by microtubulues. Actions of colchicine and chemotactic factor, J. Biol. Chem., 255:2659.PubMedGoogle Scholar
  48. Hammerling, U., Chin, A.F., Abbot, J., Goldstein, G., Sonnenberg, M., and Hoffmann, M.K., 1976, Ontogeny of B-lymphocytes. 3. Opposite signals transmitted to B-lymphocyte precursor cells by inducing agents and hormones, Eur. J. Immunol., 6:868.CrossRefGoogle Scholar
  49. Hatch, G.E., Nichols, W.K., and Hill, H.R., 1977, Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators, J. Immunol., 119:450.PubMedGoogle Scholar
  50. Hellerstrom, C., Taljedal, I., and Hellman, B., 1965, Quantitative studies on isolated pancreatic islets of mammals. 5′ nucleotidase and adenosine triphosphate activities in normal and cortisone-treated rats, Endocrinol., 76:315.CrossRefGoogle Scholar
  51. Hirata, F., Toyoshima, S., Axelrod, J., and Waxdal, J., 1980, Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis, Proc. Natl. Acad. Sci., USA, 77:862.PubMedCrossRefGoogle Scholar
  52. Hui, D.Y., and Harmony, J.A., 1980a, Inhibition of CA2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins, Proc. Natl. Acad. Sci., USA, 77:4764.PubMedCrossRefGoogle Scholar
  53. Hui, D.Y., and Harmony, J.A., 1980b, Inhibition by low density lipoproteins of mitogen-stimulated cyclic nucleotide production by lymphocytes, J. Biol. Chem., 255:1413.PubMedGoogle Scholar
  54. Humes, J.L., Bonney, R.J., Peius, L., Dahlgren, M.E., Sadowski, S.J., Kuehl, F.A., Jr., and Davies, P., 1977, Macrophages synthetize and release prostaglandins in response to inflammatory stimuli, Nature, 269:149.PubMedCrossRefGoogle Scholar
  55. Ignarro, L.J., 1977, Regulation of polymorphonuclear leukocyte, macrophage, and platelet function, in: “Immunopharmacology,” Vol. 3, J.W. Hadden, R.G. Coffey, and F. Spreafico, eds., Plenum Publishing Corp., New York, p. 61.CrossRefGoogle Scholar
  56. Ignarro, L.J., Lint, T.F., and Goerge, W.J., 1974, Hormonal control of lysosomal enzyme release from human neutrophils. Effects of autonomic agents on enzyme release, phagocytosis and cyclic nucleotide levels, J. Exp. Med., 139:1395.PubMedCrossRefGoogle Scholar
  57. Ismai-Beigi, F., and Edelman, I.S., 1971, The mechanism of calorigenic action of thyroid hormone, J. Gen. Physiol., 57:710.CrossRefGoogle Scholar
  58. Johnson, H.M., Blalock, J.E., and Baron, S., 1977, Separation of mitogen-induced suppressor and helper cell activities during inhibition of interferon production by cyclic AMP, Cell. Immunol., 33:170.PubMedCrossRefGoogle Scholar
  59. Katz, S.P., Kierszenbaum, F., and Waksman, B.H., 1978, Mechanisms of action of “lymphocyte-activating factor,” (LAF). III. Evidence that LAF acts on stimulated lymphocytes by raising cyclic GMP in G1 J. Immunol., 121:2386.PubMedGoogle Scholar
  60. Kook, A., and Trainin, N., 1974, Hormone-like activity of a thymus humoral factor on the induction of immune competence in lymphoid cells, J. Exp. Med., 139:193.PubMedCrossRefGoogle Scholar
  61. Koopman, W.J., Gillis, M.H., and David, J.R., 1973, Prevention of MIF activity by agents known to increase cellular cyclic AMP, J. Immunol., 110:1609.PubMedGoogle Scholar
  62. Mowat, A.G., and Baum, J., 1971, Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus, New Engl. J. Med., 284:621.PubMedCrossRefGoogle Scholar
  63. Novogrodsky, A., Rubin, A.L., and Stenzel, K.H., 1979, Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blasto-genesis induced by different mitogens, J. Immunol., 122:1.PubMedGoogle Scholar
  64. Kruisbeek, A.M., Astaldi, G.C.B., Blankwater, M.J., Zijlstra, J.J., Levert, L.A., and Astaldi, A., 1978, The in vitro effect of a thymic epithelial culture supernatant on mixed lymphocyte reactivity and intracellular cAMP levels of thymocytes and on antibody production to SRBC by Nu/Nu spleen cells, Cell. Immunol., 35:134.PubMedCrossRefGoogle Scholar
  65. Kumagai, J.-I., Akiyama, H., Iwashita, S., Iida, H., and Yahara, I., 1981, In vitro generation of resting lymphocytes from stimulated lymphocytes and its inhibition by insulin, J. Immunol., 126:1249.PubMedGoogle Scholar
  66. Kurland, J.I., Hadden, J.W., and Moore, M.A.S., 1977, Role of cyclic nucleotides in the preparation of committed granulocyte--macrophage progenitor cells, Cancer Res., 37:4535.Google Scholar
  67. MacManus, J.P., Whitfield, J.F, Boynton, A.L., and Rixon, R.H., 1975, Role of cyclic nucleotides and calcium in the positive control of cell proliferation, in: “Advances in Cyclic Nucleotide Research,” vol. 5, G.I. Drummond, P. Greengard, and Robinson, G.A., eds., Raven Press, New York, p. 719.Google Scholar
  68. Manganiello, V., Evans, W.H., Stossel, T.P., Mason, R.J., and Vaughan, M., 1971, The effect of polystyrene beads of cyclic 3′, 5′-adenosine monophosphate concentration in leukocytes, J. Clin. Invest., 50:2741.PubMedCrossRefGoogle Scholar
  69. Marone, G., Thomas, L.L., and Lichtenstein, L.M., 1980, The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes, J. Immunol., 125:2277.PubMedGoogle Scholar
  70. McCarthy, J.B., Wahl, S.M., Rees, J.C., Olsen, C.E., Sandberg, A.L., and Wahl, L.M., 1980, Mediation of macrophage collagenase production by 3′-5′cyclic adenosine monophosphate, J. Immunol., 124:2405.PubMedGoogle Scholar
  71. Morgan, J.I., Hall, A.K., and Perris, A.D., 1975, Requirements for divalent cations by hormonal mitogens and their interactions with sex steroids, Biochem. Biophys. Res. Comm., 66:188.PubMedCrossRefGoogle Scholar
  72. Morgan, J.I., Hall, A.K., and Perris, A.D., 1978, The ionic dependence and steroid blockade of cyclic nucleotide-induced mitogenesis in isolated rat thymic lymphocytes, J. Cyclic. Nucl. Res., 3:303.Google Scholar
  73. Munck, A., and Leung, K., 1977, Glucocorticoid receptors and mechanism of action, in: “Receptors and Mechanism of Action of Steroid Hormones,” Part II. J.R. Pasquatini, ed., Marcel Dekker, Inc., New York, p. 311.Google Scholar
  74. Munck, A., and Young, D.A., 1975, Corticosteroids and lymphoid tissue, in: “Handbook of Physiology,” Section 7, Endocrinology, vol. 6, American Physiological Society, Washington, D.C., p. 231.Google Scholar
  75. Najjar, V.A., and Schmidt, J.J., 1980, The chemistry and biology of tuftsin, Lymphokine Reports, 1:157.Google Scholar
  76. Naylor, P.H., Sheppard, H., Thurman, G.B., and Goldstein, A.L., 1976, Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5, Biochem. Biophys. Res. Comm., 73:843.PubMedCrossRefGoogle Scholar
  77. Oropeza-Rendon, R.L., Speth, V., Hiller, G., Weber, K., and Fischer, H., 1979, Prostaglandin E reversibly induced morphological changes in macrophages and inhibits phagocytosis, Exp. Cell. Res., 119:365.PubMedCrossRefGoogle Scholar
  78. Papadimitrious, J.M., and Sforcina, D., 1975, The effects of drugs on monocytic fusion in vivo, Exp. Cell. Res., 91:233.CrossRefGoogle Scholar
  79. Parrillo, J.E., and Fauci, A.S., 1979, Mechanisms of glucocorticoid action on immune processes, Ann. Rev. Pharmacol. Toxicol., 19:179.CrossRefGoogle Scholar
  80. Park, B.H., Good, R.A., Beck, N.P., and Davis, B.B., 1971, Concentration of cyclic adenosine 3′, 5′-monophosphate in human leukocytes during phagocytosis, Nature, New Biol., 229:27.Google Scholar
  81. Parker, C.W., 1976, Control of lymphocyte function, New. Engl. J. Med., 295:1180.CrossRefGoogle Scholar
  82. Parker, C.W., Kelly, J.P., Falkenhein, S.F., and Huber, M.G., 1979, Release of arachidonic acid from human lymphocytes in response to mitogenic lectins, J. Exp. Med., 149:1487.PubMedCrossRefGoogle Scholar
  83. Pick, E., 1972, Cyclic AMP affects macrophage migration, Nature, New Biol., 238:176.Google Scholar
  84. Pick, E., 1977, Lymphokines: physiologic control and pharmacological modulation of their production and action, in: “Immunophar-macology,” vol. 3, J.W. Hadden, R.G. Coffey, and F. Spreafico, eds., Plenum Publishing Corp., New York, p. 163.CrossRefGoogle Scholar
  85. Pick, E., Seger, M., Honig, S., and Griffel, B., 1979, Intracellular mediation of lymphokine action: mimicry of migration inhibitory factor (MIF) action by phorbol myristate acetate (PMA) and the ionophore A23 187, Ann. N.Y. Acad. Sci., 332:378.PubMedCrossRefGoogle Scholar
  86. Prieur, A.M., and Granger, G.A., 1975, The effects of agents which modulate levels of the cyclic nucleotides on human lym-photoxin secretion and activity in vitro, Transplantation, 20:331.PubMedCrossRefGoogle Scholar
  87. Pryzwansky, K.B., Steiner, A.L., Spitznagel, J.K., and Kapoor, C.L., 1981, Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes, Science, 211:407.PubMedCrossRefGoogle Scholar
  88. Resch, K., 1976, Membrane associated events in lymphocyte activation, in: “Receptors and Recognition Series A,” vol. 1, P. Cuatrecasas, and M.F., Greaves, eds., Chapman and Hall, London, p. 61.Google Scholar
  89. Rhodes, J., 1975, Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides, Nature, 257:597.PubMedCrossRefGoogle Scholar
  90. Rocklin, R.E., 1977, Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation, J. Immunol., 118:1734.PubMedGoogle Scholar
  91. Roder, J.C., and Klein, M., 1979, Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides, J. Immunol., 123:2785.PubMedGoogle Scholar
  92. Rossi, F., Romeo, D., and Patriarca, P., 1972, Mechanism of phagocytosis-associated oxidative metabolism in polymorphonuclear leukocytes and macrophages, J. Reticuloendothel. Soc., 12:127.PubMedGoogle Scholar
  93. Rouveix, B., Badenoch-Jones, P., Larno, S., and Turk, J.L., 1980, Lymphokine-induced macrophage aggregation: the possible role of cyclic nucleotides, Immunopharmacol., 2:319.CrossRefGoogle Scholar
  94. Rubin, M.S., Swislocki, N.I., and Sonnenberg, M., 1973, Alteration of liver plasma membrane protein conformation by bovin growth hormone in vitro, Arch. Biochem. Biophys., 157:243.PubMedCrossRefGoogle Scholar
  95. Scheid, M.P., Goldstein, G., and Boyse, E.A., 1978, The generation and regulation of lympohocyte populations, Evidence from diffe-rentiative induction systems in vitro, J. Exp. Med., 147:1727.PubMedCrossRefGoogle Scholar
  96. Scheid, M.P., Goldstein, G., Hammerling, U., and Boyse, E.A., 1975, Induction of T and B lymphocyte differentiation in vitro, in: “Membrane Receptors in Lymphocytes” M. Seligman, J.L., Preudhomme, and F.M., Kourelsky, eds., Elsevier Publishing Co., New York, p. 162.Google Scholar
  97. Schreiner, G.F., and Unanue, E.R., 1975, The modulation of spontaneous and anti-Ig-stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents, J. Immunol., 114:802.PubMedGoogle Scholar
  98. Schultz, R.M., Pavlidis, N.A., Stylos, W.A., and Chirigos, M.A., 1978, Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series, Science, 202:320.PubMedCrossRefGoogle Scholar
  99. Schumm, D.E., Morris, H.P., and Webb, T.E., 1974, Early biochemical changes in phytohemagglutinin-stimulated peripheral blood lymphocytes from normal and tumor-bearing rats, Eur. J. Cancer, 10:107.PubMedGoogle Scholar
  100. Showell, H.J., Naccache, P., Sha’afi, R.I., Becker, E.L., 1980, Inhibition of rabbit neutrophil lysosomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acid, Life Sci., 27:421.PubMedCrossRefGoogle Scholar
  101. Simochowitz, L., Fischbein, L.C., Spilberg, I., and Atkinson, J.P., 1980, Induction of a transient elevation of intracellular levels of adenosine — 3′, 5′-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation, J. Immunol., 124:1482.Google Scholar
  102. Smith, K.A., 1980, T-cell growth factor, Immunological Rev., 51:337.CrossRefGoogle Scholar
  103. Smith, R.J., and Ignarro, L.J., 1975, Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3′:5′-monophosphate and calcium in stimulus-secretion coupling, Proc. Natl. Acad. Sci., USA, 72:108.PubMedCrossRefGoogle Scholar
  104. Smith, R.L., and Weidemann, M.J., 1980, Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages, Biochem. Biophys. Res. Comm., 96:973.CrossRefGoogle Scholar
  105. Smith, R.L., Hunt, N.H., Merritt, J.E., Evants, T., and Weidemann, M.J., 1980, Cyclic nucleotide metabolism and reactive oxygen production by macrophages, Biochem. Biophys. Res. Comm., 96:1079.PubMedCrossRefGoogle Scholar
  106. Smolen, J.E., and Weissmann, G., 1981, Stimuli which provoke secretion of azurophil enzymes from human neutrophils induce increments in adenosine cyclic 3′-5′-monophosphate, Biochem. Biophys. Acta, 672:197.PubMedCrossRefGoogle Scholar
  107. Snow, C.E., Feldbush, T.L., and Oaks, J.A., 1980, The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro, J. Immunol., 124:739.PubMedGoogle Scholar
  108. Snow, CE., Feldbush, T.L., and Oaks, J.A., 1981, The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes, J. Immunol., 126:161.PubMedGoogle Scholar
  109. Spach, C., and Aschkenasy, A., 1979, Effects of a protein-free diet on the changes in cyclic AMP and cyclic GMP levels induced by immunization in splenic T and B lymphocytes in the rat, J. Nutr., 109:1265.PubMedGoogle Scholar
  110. Stenson, W.F., and Parker, C.W., 1979, Metabolism of arachidonic acid in ionophore-stimulated neutrophils, J. Clin. Invest., 64:1457.PubMedCrossRefGoogle Scholar
  111. Stenson, W.F., and Parker, C.W., 1980, Prostaglandins, macrophages, and immunity, J. Immunol., 125:1.PubMedGoogle Scholar
  112. Stossel, T.P., Murad, F., Mason, R.J., and Vaughan, M., 1970, Regulation of glycogen metabolism in polymorphonuclear leukocytes, J. Biol. Chem., 245:6228.PubMedGoogle Scholar
  113. Strom, T.B., and Carpenter, C.B., 1977, Regulation of alloimmunity by cyclic nucleotides, in: “Immunopharmacology,” Vol. 3, J.W., Hadden, R.G., Coffey, and F., Spreafico, eds., Plenum Publishing Corp., New York, p. 47.CrossRefGoogle Scholar
  114. Strom, T.B., Lundin, A.P., III, and Carpenter, C.B., 1977, The role of cyclic nucleotides in lymphocyte activation and function, in: “Progress in Clinical Immunology,” Vol. 3, R.S., Schwartz, ed., Grune and Stratton, New York, p. 115.Google Scholar
  115. Sunshine, G.H., Basch, R.S., Coffey, R.G., Cohen, K.W., Goldstein, G., and Hadden, J.W., 1978, Thymopoietin enhances the allogeneic response and cyclic nucleotide levels of mouse peripheral, thymus derived lymphocytes, J. Immunol., 120:1594.PubMedGoogle Scholar
  116. Taetle, R., and Koessler, A., 1980, Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation, Cancer Res., 40:1223.PubMedGoogle Scholar
  117. Talal, N., Roubinian, J.R., Dauphinee, M.J., Jones, L.A., and Siiteri, P.K., 1981, Effects of sex hormones on spontaneous autoimmune disease in NZB/NZW hybrid mice, in: “Advances in Immunopharmacology,” J.W., Hadden, L., Chedid, P., Mullen, and F., Spreafico, eds., Pergamon Press, Oxford, p. 127.Google Scholar
  118. Tam, C.F. and Wâlford, R.L., 1978, Cyclic nucleotide levels in resting and mitogen-stimulated spleen cell suspensions from young and old mice, Mech. Age. Develop., 7:309.CrossRefGoogle Scholar
  119. Tam, C.F. and Walford, R.L., 1980, Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of ageing normal humans and patients with Down’s syndrome, J. Immunol., 125:1665.PubMedGoogle Scholar
  120. Teh, H.S. and Paetkau, 1976, Regulation of immune response. II. The cellular basis of cyclic AMP effects on humoral immunity., Cell. Immunol., 24:220.PubMedCrossRefGoogle Scholar
  121. Triglia, D. and Rothenberg, E., 1981, “Mature” thymocytes are not glucocorticoid — resistant in vitro, J. Immunol., 127:64.PubMedGoogle Scholar
  122. Vassalli, J.D., Hamilton, J. and Reich, E., 1976, Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate, Cell, 11:695.CrossRefGoogle Scholar
  123. Wagshal, A.B., Jegasothy, B.V., and Waksman, B.H., 1978, Regulatory substances produced by lymphocytes. II. Cell cyclic specificity of inhibitor of DNA synthesis action in lymphocytes, J. Exp. Med., 147:171.PubMedCrossRefGoogle Scholar
  124. Wahl, S.M., and Wahl, L.M., 1979, Lymphokine modulation of connective tissue metabolism, Ann. N.Y. Acad. Sci., 332:411.PubMedCrossRefGoogle Scholar
  125. Wahl, S., Wahl, L., McCarthy, J., Chedid, L., and Mergenhagen, S., 1979, Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide, J. Immunol., 122:2226.PubMedGoogle Scholar
  126. Waksman, B.H., Dessaint, J.-P., and Katz, S.P., 1980, Proteolysis, calcium, and cyclic nucleotides in macrophage T-lymphocyte interaction, in “Biochemical Characterization of Lymphokines,” A.L., deWeck, F., Krinstensen, and M., Landy, eds., Academic Press, New York, p. 435.Google Scholar
  127. Wang, T., Sheppard, J.R., and Foker, J.E., 1978, Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis, Science, 201:155.PubMedCrossRefGoogle Scholar
  128. Watson, J., 1977, Involvement of cyclic nucleotides as intracellular mediators in the induction of antibody synthesis, in: “Immunopharmacology,” vol.3, J.W., Hadden, R.G., Coffey, and F., Spreafico, eds., Plenum Publishing Corp., New York, p. 29.CrossRefGoogle Scholar
  129. Webb, D.R., and Jamieson, A.T., 1976, Control of mitogen-induced transformation: characterization of a splenic suppressor cell. and its modes of action, Cell Immunol., 24:45.PubMedCrossRefGoogle Scholar
  130. Wedner, H.J., and Parker, C.W., 1976, Lymphocyte activation, Prog. in Allergy, 20:195.CrossRefGoogle Scholar
  131. Wedner, H.J., and Parker, C.W., 1977, Adenylate cyclase activity in lymphocyte subcellular fractions, Characterization of a nuclear adenylate cyclase, Biochem. J., 162:483.PubMedGoogle Scholar
  132. Weissemann, G., Dukor, P., and Zurier, R.B., 1971, Effects of cyclic AMP on release of lysosomal enzymes from phagocytes, Nature, New Biol., 231:131.Google Scholar
  133. Weissmann, G., Korchak, H.M., Perez, H.D., Smolen, J.E., Goldstein, I.M., and Hoffstein, S.T., 1979, The secretory code of the neutrophil, J. Reticuloendothel. Soc., 26 (Supp.):687.PubMedGoogle Scholar
  134. Weissmann, G., Smolen, J., and Korchak, H., 1980, Release of inflammatory mediatory from stimulant neutrophils, New Engl. J. Med., 303:27.PubMedCrossRefGoogle Scholar
  135. Welscher, H.D., and Cruchaud, A., 1976, The influence of various particles and 3’, 5’ cyclic adenosine monophosphate on release of lysosomal enzymes by mouse macrophages, J. Reticuloendothel. Soc., 20:405.PubMedGoogle Scholar
  136. Welscher, H.D., and Cruchaud, A., 1978, Conditions for maximal synthesis of cyclic AMP by mouse macrophages in response to adrenergic stimulation, Eur. J. Immunol., 8:180.PubMedCrossRefGoogle Scholar
  137. Whitfield, J.F., 1980, The regulation of cell proliferation by calcium and cyclic AMP, Mol. Cell. Biochem., 27:155.CrossRefGoogle Scholar
  138. Whitfield, J.F., MacManus, J.P., Rixon, R.H., Boynton, A.L., Yondale, T., and Sweirenga, S., 1976, Positive control of cell proliferation by interplay of calcium and cyclic nucleotides, In Vitro, 12:1.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • John W. Hadden
    • 1
  1. 1.Laboratory of ImmunopharmacologyMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations